Corrigendum: High expression of PARP1 in tumor and stroma cells predicts prognosis and platinum resistance in patients with advanced epithelial ovarian cancer

Front Oncol. 2023 Jun 27:13:1218746. doi: 10.3389/fonc.2023.1218746. eCollection 2023.

Wei-Wei Zuo^{1

2}, Chun-Fang Zhao³, Yan Li⁴, Hai-Yan Sun¹, Guo-Ming Ma⁵, Yue-Ping Liu⁶, Shan Kang¹

¹ Department of Gynecology, Fourth Hospital, Hebei Medical University, Shijiazhuang, China.
² Department of Gynecology, Tangshan People's Hospital, Tangshan, China.
³ Department of Histoplasty and Embryology, Hebei Medical University, Shijiazhuang, China.
⁴ Department of Molecular Biology, Fourth Hospital, Hebei Medical University, Shijiazhuang, China.
⁵ Department of gastrointestinal surgery, Tangshan People's Hospital, Tangshan, China.
⁶ Department of Pathology, Hebei Medical University, Fourth Hospital, Shijiazhuang, China.

Abstract

[This corrects the article DOI: 10.3389/fonc.2022.931445.].

Keywords: PARP1; advanced epithelial ovarian cancer; cytokeratin; platinum resistance; prognosis.